Recent 13F Filings
Article
Here are five of pension funds' favorite stocks from the first quarter of 2012.
5/23/12 12:17PM
Article
The two hedge fund managers differ on Yahoo and Expedia.
5/16/12 7:19AM
Article
A closer look at 13F regulatory filings in the biotech sector for the first quarter.
5/16/12 7:10AM
Article
Legendary investor George Soros slashed his stake in Apple, while cutting his exposure to tech in general.
5/15/12 6:05PM
Article
Hedge funds Moore Capital and Tudor made large JPMorgan investments in the first quarter.
5/15/12 5:30PM
Article
Watch to see if JPMorgan's share slide hits hedge funds as they disclose first-quarter positions.
5/15/12 10:04AM
Article
Stakes in AIG and Sears remain unchanged in fiscal first quarter.
4/26/12 11:24AM
Article
AutoZone has aggressively bought back shares even as the company has grown.
3/28/12 11:26AM
Article
These stocks caught the attention of Insider Monkey last week.
3/17/12 7:00AM
Article
Here's a look at seven stocks that Soros Fund Management bought in the most recently reported quarter.
3/12/12 6:08AM
Article
Here's a look at eight stocks that Paulson & Co. bought in the fourth quarter.
3/9/12 6:02AM
Article
The activist hedge fund investor joins his peers in holding shares of the tech giant.
3/2/12 1:07PM
Article
Apple, Google and Microsoft are among hedge funds' 10 favorite stocks.
2/29/12 11:14AM
Article
Here are 10 of the biggest dividend-paying holdings of Buffett's Berkshire Hathaway.
2/28/12 6:21AM
Article
We believe Boston Scientific is a speculative play on take-over rumors; Oracle pays a dividend and has earnings growth potential.
2/24/12 11:57AM
Article
Berkshire's latest hires were influential in stock picks in the fourth quarter.
2/17/12 6:00AM
Article
The smart money is positioning portfolios to recover from losses in 2011.
2/16/12 3:30PM
Article
The hedge fund manager sold his stake after buying it three months earlier.
2/15/12 12:12PM
Article
Hedge fund SAC Capital has purchased more shares of Apple and Gilead Sciences.
2/15/12 11:28AM
Article
Some of Wall Street's largest investors, including SAC Capital's Steven Cohen are making big plays for hepatitis C drug stocks
2/15/12 10:44AM
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Connect with TheStreet